What are the guidelines for post-operative contouring for a glioma CNS (Central Nervous System) grade 2?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Operative Contouring Guidelines for CNS Grade 2 Glioma

For CNS grade 2 gliomas, the gross tumor volume (GTV) should be defined using T2/FLAIR signal abnormalities on MRI, with a clinical target volume (CTV) expansion of 10 mm, and a total radiation dose of 50.4 Gy in 28 fractions (or 50-54 Gy in 1.8-2.0 Gy fractions). 1, 2

Imaging Requirements for Target Delineation

Pre-Treatment Imaging

  • MRI is the standard imaging modality for both diagnosis and target volume delineation in grade 2 gliomas 2
  • Obtain postoperative MRI within 24-72 hours to establish baseline and assess extent of resection 2
  • Use both pre-operative and post-operative MRI fused together for optimal target definition 2, 1

Imaging Sequences for Contouring

  • T2-weighted and FLAIR sequences are the primary imaging modalities for defining the GTV in grade 2 gliomas 2, 1
  • The GTV should include the entire T2/FLAIR signal abnormality, as this represents the infiltrative tumor extent 1
  • T1 post-contrast sequences should be reviewed, though grade 2 gliomas typically do not enhance 3

Target Volume Delineation Algorithm

Step 1: Define the Gross Tumor Volume (GTV)

  • Include all residual tumor visible on postoperative imaging 1
  • Include the entire resection cavity 1
  • Include all T2/FLAIR signal abnormalities that represent tumor infiltration 1
  • For optimal resection cases, the GTV encompasses the tumor volume defined in T2 and/or FLAIR sequence 2

Step 2: Create the Clinical Target Volume (CTV)

  • Expand the GTV by 10 mm to create the CTV for grade 2 gliomas 1
  • This margin accounts for microscopic tumor infiltration beyond visible imaging abnormalities 1
  • The more recent ESTRO-EANO guideline specifically recommends 10 mm for grade 2 tumors, which is more conservative than older recommendations of 1-2 cm 1, 2

Step 3: Planning Target Volume (PTV)

  • Add institutional setup margin (typically 3-5 mm) to account for daily setup variability and patient motion 1

Radiation Dose and Fractionation

The recommended dose is 50.4 Gy in 28 fractions (1.8 Gy per fraction), based on the most recent ESTRO-EANO guidelines 1. Alternative acceptable regimens include:

  • 50-54 Gy in 1.8-2.0 Gy fractions 2
  • The dose range of 45-54 Gy is considered standard, with preference for 50-54 Gy 2

Technical Considerations

Radiation Technique

  • IMRT (Intensity-Modulated Radiation Therapy) is the preferred approach for grade 2 gliomas 1
  • Proton therapy may be considered when available 1
  • Stereotactic radiosurgery (SRS) has NOT been established as appropriate for low-grade gliomas and should not be used as initial treatment 2

Critical Pitfalls to Avoid

  • Do not use whole-brain radiation therapy - localized treatment fields are standard to minimize toxicity 4
  • Do not include vasogenic edema in the GTV if it can be distinguished from tumor infiltration (though this is less of an issue in grade 2 than grade 3-4 gliomas) 1
  • Do not delay postoperative imaging beyond 72 hours, as this baseline is critical for future response assessment 2

Special Considerations by Histology

Oligodendroglioma Grade 2

  • Follow the same contouring principles as above 1
  • These tumors are typically well-demarcated and may contain calcifications 3
  • Molecular testing for IDH mutation and 1p/19q codeletion should be confirmed, as this affects overall treatment strategy 3

Astrocytoma Grade 2

  • More infiltrative pattern may be present 1
  • T2/FLAIR abnormalities are particularly important to capture the full extent 1

Quality Assurance

  • Ensure experienced neuropathologist review of tissue 2
  • Multidisciplinary consultation should guide treatment decisions 2
  • Use neuronavigation software to accurately fuse pre- and post-operative imaging 1

References

Research

ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tratamento de Oligodendroglioma Grau 2

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.